TAM (Treatments and Medicines) NHS Highland
Important: Therapy notes
Important: Formulation and dosage details
Formulation:
Concentrate for solution for infusion 250mg/2·5mL (Restricted: hospital use only)
Other parenteral anticoagulants (Formulary: Cardiovascular)
- Policy for extended venous thromboembolism (VTE) prophylaxis on discharge from hospital.
- Thrombosis and embolism during pregnancy and the puerperium, reducing the risk (Green-top Guideline No 37a) at https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a/.
Important: Therapy notes
Classification: Hirudins
Important: Formulation and dosage details
Formulation:
Powder for solution for injection 250mg (Restricted: hospital use only)
Dosage:
For use in patients with acute coronary syndrome undergoing percutaneous coronary intervention with a higher bleeding risk.
Important: Therapy notes
Classification: Heparinoids
Important: Formulation and dosage details
Formulation:
Injection 750 units/0·6mL (s)
Important: Therapy notes
Important: Formulation and dosage details
Formulation:
Powder for solution for infusion 500 micrograms (Restricted: hospital use only)
Important: Therapy notes
Important: Formulation and dosage details
Formulation:
Injection 2·5mg/0·5mL
Dosage:
Refer to Raigmore Hospital guidance on management of non-ST elevation ACS/Non-STEMI: Acute coronary syndrome
Important: Therapy notes
Important: Formulation and dosage details
Formulation:
Injection 5,000 units/5mL, 20,000 units/20mL, 25,000 units/5mL
Important: Formulation and dosage details
Formulation:
Subcutaneous injection 5,000 units/0·2mL
Important: Formulation and dosage details
Formulation:
Flush solution 50 units/5mL